Xspray Pharma AB (publ) (STO:XSPRAY)
Sweden flag Sweden · Delayed Price · Currency is SEK
15.60
+0.02 (0.13%)
Jul 24, 2026, 4:18 PM CET

Xspray Pharma AB Financials Overview

Millions SEK. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
5.076.432.131.772.180.66
Revenue Growth
30.46%206.87%-93.40%1357.20%232.32%-51.91%
Gross Profit
5.076.432.131.772.180.66
Operating Income
-149.12-156.91-287.04-181.73-133.07-97.95
Net Income
-164.52-171.44-285.52-179.67-131.67-96.7
Earnings Per Share
-5.34-4.46-8.62-6.76-6.25-5.03
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
120.72153.75208.24166.3120.17271.88
Total Debt
147.85148.39128.2236.812.133.23
Net Cash (Debt)
-27.135.3580.02129.5118.04268.65
Net Cash Growth
--93.31%-38.21%9.70%-56.06%-16.23%
Net Cash Per Share
-0.690.142.414.875.6013.96

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-157.51-193.16-222.37-203.28-110.18-51.61
Capital Expenditures
---4.38-2.69-24.47-1.31
Free Cash Flow
-157.51-193.16-226.75-205.97-134.65-52.92
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-2942.87%-2439.52%-13694.70%-572.08%-6104.27%-14931.90%
Pretax Margin
-3248.59%-2667.07%-13629.48%-565.63%-6039.91%-14740.55%
Profit Margin
-3250.38%-2668.69%-13636.70%-565.69%-6039.91%-14740.50%
FCF Margin
-3108.57%-3003.16%-10818.10%-648.37%-6176.38%-8067.07%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-3.762.022.6214.5314.53
PS Ratio
299.57204.10734.4439.35593.022020.75